Valeant OTC Strategy Leverages “Relationships With Doctors”
This article was originally published in The Tan Sheet
Executive Summary
The Canadian specialty pharma firm plans to continue bolt-on acquisitions in 2014, including more OTC products that are doctor recommended, executives say.